New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment

Psychosomatics

Volumn 40, Issue 5, 1999, Pages 438-443

  Goldstein, Lee E ^a   Sporn, Jonathan ^b   Brown, Susan ^b   Helen, Kim ^b   Finkelstein, Joan ^b   Gaffey, Gail K ^b   Sachs, Gary ^b   Stern, Theodore A ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CARBAMAZEPINE; CEFOTETAN; CLONAZEPAM; CLOZAPINE; GLIBENCLAMIDE; GLUCOSE; HALOPERIDOL; HUMAN INSULIN; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; INSULIN; ISOPHANE INSULIN; LAMOTRIGINE; LEVOTHYROXINE; LISINOPRIL; LITHIUM CARBONATE; LORAZEPAM; METFORMIN; OLANZAPINE; OMEPRAZOLE; PAROXETINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SERTRALINE; TIOTIXENE; TROGLITAZONE; VALPROIC ACID;

ADULT; ANTIBIOTIC THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MANIC DEPRESSIVE PSYCHOSIS; PANCREATITIS; RECEPTOR AFFINITY; SCHIZOIDISM; SCHIZOPHRENIA;

EID: 0032818505     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(99)71210-7     Document Type: Article

References (22)

1. Janicak P, Davis J, Preskorn S, et al: Principles and Practice of Psychopharmacology, 2nd Edition. Baltimore, MD, Williams & Wilkins, 1997
2. Kamran A, Doraiswamy PM, Jane JL, et al: Severe hyperglycemia associated with high doses of clozapine (letter). Am J Psychiatry 1994; 151:1395
3. Koval MS, Rames LJ, Christie S: Diabetic ketoacidosis associated with clozapine treatment. Am J Psychiatry 1994; 151:1520-1521
4. Kostakoglu AE, Yazici KM, Erbas T, et al: Ketoacidosis as a side-effect of clozapine: a case report. Acta Psychiatr Scand 1996; 93:217-218
5. Peterson GA, Byrd SL: Diabetic ketoacidosis from clozapine and lithium cotreatment. Am J Psychiatry 1996; 153:737-738
6. Koren W, Kreis Y, Duchowiczny K, et al: Lactic acidosis and fatal myocardial failure due to clozapine. Ann Pharmacother 1997; 41:168-170
7. Popli AP, Konicki PE, Jurjus GJ, et al: Clozapine and associated diabetes mellitus. J Clin Psychiatry 1997; 58:108-111
8. Wirthing DA, Spellberg BJ, Erhart SM, et al: Novel antipsychotics and new-onset diabetes. Biol Psychiatry 1998; 44:778-783
9. Sporn J, Goldstein L, Brown S, et al: Hyperglycemia associated with olanzapine (abstract). Annual Meeting of the American Psychiatric Association, May 30-June 4, 1998; Toronto, Canada, p. 250
10. Martin A: Acute pancreatitis associated with clozapine use (letter). Am J Psychiatry 1992; 149:714
11. Jubert P: Clozapine-related pancreatitis: Ann Intern Med 1994; 121:722-723 (published erratum appears in Ann Intern Med 1995; 122:397)
12. Allison DB, Mentore JL, Heo M, et al: Weight gain associated with conventional and newer antipsychotics: a meta-analysis (abstract). Annual Meeting of the New Clinical Drug Evaluation Unit Program, June 10-13, 1998; Boca Raton, FL, p. 113
13. Stanton JM: Weight gain associated with neuroleptic medication: a review. Schizophr Bull 1995; 21:463-472
14. Masand PS: Weight gain associated with atypical antipsychotics. Journal of Psychotic Disorders 1998; 2:4-6
15. Leadbetter R, Shutty M, Pavalonis D, et al: Clozapine-induced weight gain: prevalence and clinical relevance. Am J Psychiatry 1992; 149:68-72
16. Frankenburg FM, Zanarini MC, Kando J, et al: Clozapine and body mass change. Biol Psychiatry 1998; 43:520-524
17. Kraus T, Haack M, Schuld A, et al: Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 1999; 156:312-314
18. Gupta S, Droney T, Al-Samarrai S, et al: Olanzapine-induced weight gain. Ann Clin Psychiatry 1998; 10:39
19. Beasley CM, Hamilton SH, Crawford AM, et al: Olanzapine vs. haloperidol: acute phase results of the international double-blind olanzapine trial. Eur Neuropsychopharmacol 1997; 7:125-137
20. Osser DN, Najarian D, Berman I, et al: Olanzapine increases weight gain and triglyceride levels (abstract). Annual Meeting of the American Psychiatric Association, 1998, NR688, p. 254
21. Casey DE: Side effect profiles of new antipsychotic agents. J Clin Psychiatry 1996; 11:40-45
22. Isojarvi JIT, Laatikainen TJ, Knip M, et al: Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996; 39:579-584